Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Marksans gets FDA ok for ibuprofen liquid-filled capsules

This article was originally published in Scrip

Executive Summary

Marksans Pharma has received US FDA approval for its ANDA for liquid-filled ibuprofen capsules 200mg, a generic version of Wyeth Consumer Healthcare's anti-inflammatory, Advil Liqui-Gels. Marksans has started manufacturing the generic at its facility in Goa, the company informed the Bombay Stock Exchange. Marksans, which expects to emerge as a global integrated generic and OTC firm, last year acquired the Hale Group, the parent company of Bell, Sons & Co (Druggists) and the generic marketing and distribution company Relonchem, both in the UK.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts